Asheboro Drug Company
Outcome
A federal court entered a consent decree on July 13, 2022, ordering Asheboro Drug Company and pharmacists Isaac F. Brady III and Isaac F. Brady IV (father and son) to pay $300,000 in civil penalties and comply with a controlled substance dispensing injunction, resolving allegations that both pharmacists filled opioid prescriptions while ignoring red flags of drug abuse and diversion.
Details
Asheboro Drug Company — Father-Son Opioid Red Flags / $300,000 Consent Decree (2022)
Outcome: U.S. District Judge Catherine C. Eagles entered a consent decree on July 13, 2022, ordering Asheboro Drug Company and its two pharmacists — Isaac F. Brady III and Isaac F. Brady IV, a father and son — to pay $300,000 in civil penalties and comply with an injunction requiring red-flag identification and documentation before dispensing certain controlled substance prescriptions.
Asheboro Drug Company is an independent pharmacy in Asheboro, Randolph County, North Carolina, operated by pharmacists Isaac F. Brady III and Isaac F. Brady IV across two generations. The DOJ filed a complaint on July 7, 2022, in the Middle District of North Carolina, alleging that both pharmacists violated the Controlled Substances Act by systematically dispensing opioids and other controlled substances while ignoring obvious red flags of drug abuse, diversion, and drug-seeking behavior.
The violations included filling prescriptions bearing multiple simultaneous red-flag indicators: dangerous drug combinations, doses exceeding medically appropriate thresholds, prescriptions from suspected pill-mill prescribers, and patterns of patient behavior consistent with drug-seeking. The complaint alleged this conduct by both pharmacists over a sustained period, suggesting that ignoring diversion red flags was the operating standard at the pharmacy rather than isolated aberrant conduct.
The consent decree entered the same day the complaint was filed — indicating that Asheboro Drug and both pharmacists cooperated with the investigation and agreed to settle without litigation. The decree prohibits filling certain red-flag prescription categories and requires documented justification before filling others, subject to periodic compliance monitoring.
Primary Source: Court Orders North Carolina Pharmacy and Pharmacists to Pay $300,000 Penalty | DOJ
How Crucible Prevents This
A father-and-son pharmacist team at the same pharmacy both engaged in systematic opioid red-flag violations — a pattern that indicates the compliance failure was embedded in the practice's culture, not isolated to one individual. Crucible's session-gate model — requiring each session operator to individually authenticate and document their compliance posture — ensures that culture-level failures cannot persist without being personally attributed and documented. When two licensed operators share the same compliance blind spots, a system requiring individual sign-off on high-risk dispensing decisions would surface the pattern before an investigation does.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works